Gene · 8200
Papers2,199
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,199
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Congenital Proximal Radioulnar Synostosis in an Elite Athlete-Case Report. | Medicina (Kaunas) | 2023 | 36984532 | PubTator, text mining | PubMed |
| Polymeric and Composite Carriers of Protein and Non-Protein Biomolecules for Application in Bone Tissue Engineering. | Materials (Basel) | 2023 | 36984115 | PubTator, text mining | PubMed |
| Tendon Disorders in Chronic Liver Disease: A Retrospective Cohort Study in Taiwan. | Int J Environ Res Public Health | 2023 | 36981892 | PubTator, text mining | PubMed |
| FGF9-Associated Multiple Synostoses Syndrome Type 3 in a Multigenerational Family. | Genes (Basel) | 2023 | 36980996 | PubTator, text mining | PubMed |
| Managing the Heterogeneity of Mesenchymal Stem Cells for Cartilage Regenerative Therapy: A Review. | Bioengineering (Basel) | 2023 | 36978745 | PubTator, text mining | PubMed |
| Epigenetics as a mediator of genetic risk in osteoarthritis: role during development, homeostasis, aging, and disease progression. | Am J Physiol Cell Physiol | 2023 | 36971423 | PubTator, text mining | PubMed |
| Stem Cell Applications and Tenogenic Differentiation Strategies for Tendon Repair. | Stem Cells Int | 2023 | 36970597 | PubTator, text mining | PubMed |
| miR-204 ameliorates osteoarthritis pain by inhibiting SP1-LRP1 signaling and blocking neuro-cartilage interaction. | Bioact Mater | 2023 | 36969105 | PubTator, text mining | PubMed |
| A common variant rs2054564 in ADAMST17 is associated with susceptibility to lumbar spondylosis. | Sci Rep | 2023 | 36966180 | PubTator, text mining | PubMed |
| Spatiotemporal Characterization of Human Early Intervertebral Disc Formation at Single-Cell Resolution. | Adv Sci (Weinh) | 2023 | 36965031 | PubTator, text mining | PubMed |
| Blockade of Activin Receptor IIB Protects Arthritis Pathogenesis by Non-Amplification of Activin A-ACVR2B-NOX4 Axis Pathway. | Adv Sci (Weinh) | 2023 | 36950748 | PubTator, text mining | PubMed |
| Extracellular vesicles in osteoarthritis of peripheral joint and temporomandibular joint. | Front Endocrinol (Lausanne) | 2023 | 36950682 | PubTator, text mining | PubMed |
| Clinical and genetic associations of deep learning-derived cardiac magnetic resonance-based left ventricular mass. | Nat Commun | 2023 | 36944631 | PubTator, text mining | PubMed |
| Comparative in vitro treatment of mesenchymal stromal cells with GDF-5 and R57A induces chondrogenic differentiation while limiting chondrogenic hypertrophy. | J Exp Orthop | 2023 | 36943593 | PubTator, text mining | PubMed |
| Peptide-functionalized double network hydrogel with compressible shape memory effect for intervertebral disc regeneration. | Bioeng Transl Med | 2023 | 36925718 | PubTator, text mining | PubMed |
| Recent advances in tendon tissue engineering strategy. | Front Bioeng Biotechnol | 2023 | 36890920 | PubTator, text mining | PubMed |
| Natural products can modulate inflammation in intervertebral disc degeneration. | Front Pharmacol | 2023 | 36874009 | PubTator, text mining | PubMed |
| Human 3D nucleus pulposus microtissue model to evaluate the potential of pre-conditioned nasal chondrocytes for the repair of degenerated intervertebral disc. | Front Bioeng Biotechnol | 2023 | 36865027 | PubTator, text mining | PubMed |
| Gene polymorphisms associated with heterogeneity and senescence characteristics of sarcopenia in chronic obstructive pulmonary disease. | J Cachexia Sarcopenia Muscle | 2023 | 36856146 | PubTator, text mining | PubMed |
| Dysregulation of innate cell types in the hepatic immune microenvironment of alcoholic liver cirrhosis. | Front Immunol | 2023 | 36845083 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8200/papers?page=14